Security key
218352102
CORCEPT THERAPEUTICS INC - COMMON STOCK (CORT)
CUSIP: 218352102
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 84,197,994
- Total 13F value
- $4,242,065,667
- Share change
- -4,315,100
- Put/Call ratio
- 132%
- SEC-reported price per share
- $50.39
- Number of holders
- 362
- Value change
- -$207,314,469
- Number of buys
- 176
- Number of sells
- 150
- Shares outstanding
- 106,815,676
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
362
Top holders
10
CORT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
CORCEPT THERAPEUTICS INC SEC filings
CORCEPT THERAPEUTICS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 218352102
Recent filing periods:
Ownership snapshot
Top reported holders of CORT - CORCEPT THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Joseph K. Belanoff
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
31 Dec 2024
13D/G
13F
Lead comparable stake: 6.3%
13D/G row: Joseph K. Belanoff
Showing 1-6 of 15 holder rows.
Quick read
Joseph K. Belanoff leads the comparable SEC ownership view at 6.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Joseph K. Belanoff's linked filing trail.
Comparable ownership
Top 5
Joseph K. Belanoff
6.3%
BlackRock, Inc.
15%
VANGUARD GROUP INC
9.4%
INGALLS & SNYDER LLC
7.7%
RENAISSANCE TECHNOLOGIES LLC
6.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Joseph K. Belanoff |
13D/G
|
6.3%
|
$499,599,592
6,822,335 shares
|
$0 | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
15%
|
$742,812,606
16,050,402 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
9.4%
|
$463,092,952
10,006,330 shares
|
— | 30 Sep 2024 |
| INGALLS & SNYDER LLC |
13F
Company
|
7.7%
|
$382,585,000
8,266,756 shares
|
— | 30 Sep 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
6.1%
|
$301,236,613
6,509,002 shares
|
— | 30 Sep 2024 |
| Parallel Advisors, LLC |
13F
Company
|
3.6%
|
$176,499,147
3,813,724 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
362
Shares
84,197,994
Rows available
362
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
316
Q4 2024 holders
362
Holder diff
46
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend